News
- Author:
- Michele G. Sullivan
Publish date: June 13, 2017
But do the findings shed any light on beta-amyloid’s role in the development of Alzheimer’s disease?
News
- Author:
- Michele G. Sullivan
Publish date: June 11, 2017
The antibody is up for study in further Crohn’s trials and for psoriasis.
News
- Author:
- Michele G. Sullivan
Publish date: June 10, 2017
C. difficile
News
- Author:
- Michele G. Sullivan
Publish date: June 7, 2017
The risk is considerably lower than what was suggested by 40-year-old registry data.
News
- Author:
- Michele G. Sullivan
Publish date: June 6, 2017
A close link with primary care significantly decreased the risk of inappropriate follow-up in patients with nondysplastic Barrett’s esophagus.
News
- Author:
- Michele G. Sullivan
Publish date: May 23, 2017
CHICAGO – Database review examines advances in management of acute pancreatitis.
News
- Author:
- Michele G. Sullivan
Publish date: May 22, 2017
CHICAGO – It is well-known that patients with chronic pancreatitis suffer physically and emotionally, but what about those with RAP?
News
- Author:
- Michele G. Sullivan
Publish date: May 18, 2017
CHICAGO – Open-capsule budesonide reduced or eliminated chronic diarrhea for patients with adult autoimmune enteropathy.
News
- Author:
- Michele G. Sullivan
Publish date: May 18, 2017
CHICAGO – Now approved for chronic idiopathic constipation, plecanatide has been presented for a supplemental new drug application for adult IBS-C....
News
- Author:
- Michele G. Sullivan
Publish date: May 17, 2017
Blood lead tests should be repeated with a capillary sample in children younger than 6 years of age as of May 17, and all pregnant or breastfeeding...
News
- Author:
- Michele G. Sullivan
Publish date: May 16, 2017
Investigational drug achieved endoscopic and clinical responses, and some patients achieved steroid-free remission.
Video
- Author:
- Michele G. Sullivan
Publish date: May 15, 2017
CHICAGO – The investigator considers it a big advantage over the Nissen fundoplication, which creates a pseudoflap that isn’t as yielding to intrag...
News
- Author:
- Michele G. Sullivan
Publish date: May 11, 2017
VIENNA – Many patients with pyogenic vertebral osteomyelitis may have an alternative to IV antibiotics during their treatment course.
News
- Author:
- Michele G. Sullivan
Publish date: May 11, 2017
VIENNA – Ribaxamase breaks down excess therapeutic antibiotics in the gut before they can damage the normal microbiome.
News
- Author:
- Michele G. Sullivan
Publish date: May 11, 2017
VIENNA – With suboptimal responses to intramuscular vaccination, the addition of a topical agent may improve hepatitis B outcomes.
